Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SIBN | US
1.08
7.94%
Healthcare
Medical Devices
30/06/2024
04/10/2024
14.68
14.03
14.70
13.91
SI-BONE Inc. a medical device company develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion adult deformity and degeneration and pelvic trauma. The company also provides iFuse-3D a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force as well as through agents and distributors. SI-BONE Inc. was incorporated in 2008 and is headquartered in Santa Clara California.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
61.2%1 month
50.5%3 months
55.4%6 months
49.2%-
-
3.39
0.24
0.18
-14.15
2.95
-
-40.61M
612.07M
612.07M
-
-25.22
-
20.00
-23.88
6.25
4.49
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.71
Range1M
3.92
Range3M
4.74
Rel. volume
1.41
Price X volume
6.16M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Cytek Biosciences Inc. Common Stock | CTKB | Medical Devices | 5.06 | 665.42M | -3.44% | n/a | 8.53% |
IRadimed Corporation | IRMD | Medical Devices | 49.82 | 631.21M | 0.50% | 33.67 | 0.47% |
OrthoPediatrics Corp | KIDS | Medical Devices | 25.93 | 627.88M | 0.23% | n/a | 3.67% |
AxoGen Inc | AXGN | Medical Devices | 13.67 | 599.59M | -3.32% | n/a | 72.14% |
Orthofix International N.V | OFIX | Medical Devices | 15.29 | 583.69M | -1.67% | n/a | 28.63% |
Paragon 28 Inc. | FNA | Medical Devices | 5.88 | 491.23M | -1.18% | n/a | 75.29% |
ZimVie Inc | ZIMV | Medical Devices | 15.96 | 440.05M | 1.08% | n/a | 63.23% |
Butterfly Network Inc. | BFLY | Medical Devices | 1.96 | 416.65M | 10.11% | n/a | 12.34% |
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares | ZJYL | Medical Instruments & Supplies | 2.51 | 392.93M | -3.83% | 141.50 | 37.91% |
MaxCyte Inc. Common Stock | MXCT | Medical Devices | 3.67 | 390.42M | -1.87% | n/a | 8.37% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
FRP Holdings Inc | FRPH | Real Estate Services | 30.13 | 573.39M | 2.27% | 74.92 | 42.65% |
HOUS | HOUS | Real Estate Services | 5.03 | 559.70M | -5.27% | n/a | 201.36% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
The RMR Group Inc | RMR | Real Estate Services | 25.49 | 426.32M | 1.27% | 16.38 | 14.14% |
RE/MAX Holdings Inc | RMAX | Real Estate Services | 11.85 | 372.29M | -4.67% | n/a | 114.28% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
STHO | STHO | Real Estate Services | 13 | 173.15M | -3.20% | n/a | 59.21% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -14.15 | 45.99 | Cheaper |
Ent. to Revenue | 2.95 | 13.20 | Cheaper |
PE Ratio | - | 29.98 | - |
Price to Book | 3.39 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 55.40 | 66.08 | Par |
Debt to Equity | 0.24 | 0.83 | Cheaper |
Debt to Assets | 0.18 | 0.28 | Cheaper |
Market Cap | 612.07M | 9.42B | Emerging |